Literature DB >> 27682074

Diagnostic and Prognostic Value of MicroRNA in Viral Diseases.

Eeva Auvinen1.   

Abstract

Virology is probably the most rapidly developing field within clinical laboratory medicine. Adequate diagnostic methods exist for the diagnostics of most acute viral infections. However, emergence of pathogenic viruses or virus strains and new disease associations of known viruses require the establishment of new diagnostic methods, sometimes very rapidly. In the field of chronic or persistent viral diseases, particularly those involving potential of malignant or fatal development, there is a constant need for improved differential diagnostics, monitoring, prognosis and risk assessment. Increasing understanding of disease pathogenesis also enables better patient management and personalized medicine, where companion diagnostics can offer precise and specific tools for individual care. Very often the new tools are offered by molecular diagnostic techniques, and this includes the detection of microRNAs (miRNAs). miRNAs are small regulatory RNA molecules, which regulate the expression of their target genes. They are encoded both by viruses and their host, and both can target either viral or cellular gene expression. In this review the diagnostic possibilities offered by miRNA will be discussed. The focus will be on selected viral and human miRNAs in viral diseases, and examples of miRNAs of putative diagnostic potential will be presented.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27682074     DOI: 10.1007/s40291-016-0236-x

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  105 in total

1.  Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells.

Authors:  Ming Shi; Libin Du; Dan Liu; Lu Qian; Meiru Hu; Ming Yu; Zhengyan Yang; Mingzhen Zhao; Changguo Chen; Liang Guo; Lina Wang; Lun Song; Yuanfang Ma; Ning Guo
Journal:  J Pathol       Date:  2012-04-18       Impact factor: 7.996

Review 2.  Viruses, microRNAs, and host interactions.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

3.  Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer.

Authors:  Qingying Wang; Jinlong Qin; Aozhen Chen; Jianhong Zhou; Jie Liu; Jiajing Cheng; Jin Qiu; Jiawen Zhang
Journal:  Tumour Biol       Date:  2015-01-06

4.  Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

Authors:  Evan M Kroh; Rachael K Parkin; Patrick S Mitchell; Muneesh Tewari
Journal:  Methods       Date:  2010-02-08       Impact factor: 3.608

5.  Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection.

Authors:  Yoshihiko Kawano; Seiko Iwata; Jun-ichi Kawada; Kensei Gotoh; Michio Suzuki; Yuka Torii; Seiji Kojima; Hiroshi Kimura; Yoshinori Ito
Journal:  J Infect Dis       Date:  2013-05-17       Impact factor: 5.226

6.  Short RNAs repress translation after initiation in mammalian cells.

Authors:  Christian P Petersen; Marie-Eve Bordeleau; Jerry Pelletier; Phillip A Sharp
Journal:  Mol Cell       Date:  2006-02-17       Impact factor: 17.970

7.  Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues.

Authors:  Heidi J Peltier; Gary J Latham
Journal:  RNA       Date:  2008-03-28       Impact factor: 4.942

8.  Dysregulated microRNA expression in serum of non-vaccinated children with varicella.

Authors:  Yuhua Qi; Zheng Zhu; Zhiyang Shi; Yiyue Ge; Kangchen Zhao; Minghao Zhou; Lunbiao Cui
Journal:  Viruses       Date:  2014-04-22       Impact factor: 5.048

9.  Hepatitis B surface antigen quantity positively correlates with plasma levels of microRNAs differentially expressed in immunological phases of chronic hepatitis B in children.

Authors:  Thilde Nordmann Winther; Ida Louise Heiberg; Claus Heiner Bang-Berthelsen; Flemming Pociot; Birthe Hogh
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

10.  MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy.

Authors:  Saif Ullah Munshi; Harekrushna Panda; Prasida Holla; Bharat Bhushan Rewari; Shahid Jameel
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

View more
  6 in total

Review 1.  Viral MicroRNAs: Interfering the Interferon Signaling.

Authors:  Imran Ahmad; Araceli Valverde; Hasan Siddiqui; Samantha Schaller; Afsar R Naqvi
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

2.  JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients.

Authors:  Pabitra Basnyat; Elina Virtanen; Irina Elovaara; Sanna Hagman; Eeva Auvinen
Journal:  J Neurovirol       Date:  2017-08-22       Impact factor: 2.643

3.  Different microRNA profiles reveal the diverse outcomes induced by EV71 and CA16 infection in human umbilical vein endothelial cells using high-throughput sequencing.

Authors:  Jie Song; Yajie Hu; Jiaqi Li; Huiwen Zheng; Jingjing Wang; Lei Guo; Ruotong Ning; Hongzhe Li; Zening Yang; Haitao Fan; Longding Liu
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

4.  MicroRNA and Nonsense Transcripts as Putative Viral Evasion Mechanisms.

Authors:  Abhijeet A Bakre; Ali Maleki; Ralph A Tripp
Journal:  Front Cell Infect Microbiol       Date:  2019-05-08       Impact factor: 5.293

5.  Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC.

Authors:  Tahereh Donyavi; Farah Bokharaei-Salim; Hossein Bannazadeh Baghi; Khadijeh Khanaliha; Mahrokh Alaei Janat-Makan; Bahareh Karimi; Javid Sadri Nahand; Hamed Mirzaei; AliReza Khatami; Saba Garshasbi; Majid Khoshmirsafa; Seyed Jalal Kiani
Journal:  Int Immunopharmacol       Date:  2021-04-06       Impact factor: 5.714

Review 6.  Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis.

Authors:  Diana Gabriela Iacob; Adelina Rosca; Simona Maria Ruta
Journal:  World J Gastroenterol       Date:  2020-03-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.